Global pharma giants Eli Lilly and Novo Nordisk are scrambling to cement their lead in India's booming obesity drug market ...

Atea Pharmaceuticals (AVIR) offers a late-stage, best-in-class HCV cure, with significant upside, currently trading below cash. BEM/RZR combines advantages of current first-line HCV therapies — single ...

Riedemann, Chief Executive Officer and Founder of InflaRx , commented: “InflaRx welcomes the granting of izicopan as the INN for INF904. We believe the promising clinical data recently reported in ...

Mercedes-Benz South Africa has quietly slashed the prices of its mainstream C-Class range – a line-up that is, of course, produced in East London – repositioning both the petrol-powered C200 and the ...